– FDA Breakthrough Designation for CIN Indication: Plinabulin for Concurrent Administration with Myelosuppressive Chemotherapeutic Regimens in Patients with Non-Myeloid Malignancies […]
-Highly statistically significant reductions in both pruritus and serum bile acids--Well tolerated with very low incidence of diarrhea--Similar efficacy in […]
Acquisition aligns with strategy for accretive acquisition and extends product offerings in DevOps and DevSecOps with market-leading infrastructure automationBEDFORD, [...]